Free Trial
NASDAQ:NMTR

9 Meters Biopharma (NMTR) Stock Price, News & Analysis

9 Meters Biopharma logo
$0.0002 0.00 (0.00%)
As of 08/6/2025

About 9 Meters Biopharma Stock (NASDAQ:NMTR)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.07
$6.56
Volume
9 shs
Average Volume
315,915 shs
Market Capitalization
$2.87 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NMTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 9 Meters Biopharma and its competitors with MarketBeat's FREE daily newsletter.

NMTR Stock News Headlines

Deal reached to sell some assets of bankrupt Raleigh firm
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
9 Meters Biopharma, Inc. (NMTRQ)
9 Meters Biopharma Inc (NMTRQ)
9 Meters Biopharma (OTC: NMTR.Q)
See More Headlines

NMTR Stock Analysis - Frequently Asked Questions

9 Meters Biopharma's stock was trading at $0.0002 at the beginning of 2025. Since then, NMTR stock has increased by 0.0% and is now trading at $0.0002.

9 Meters Biopharma, Inc. (NASDAQ:NMTR) released its quarterly earnings data on Monday, November, 15th. The company reported ($1.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.74) by $0.26.

9 Meters Biopharma shares reverse split on Tuesday, October 18th 2022.The 1-20 reverse split was announced on Tuesday, October 18th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, October 18th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of NMTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 9 Meters Biopharma investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), SNDL (SNDL), NIO (NIO), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/15/2021
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NMTR
CIK
1551986
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.77 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-584.97%
Return on Assets
-159.45%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.59
Quick Ratio
0.59

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
14,336,000
Free Float
13,992,000
Market Cap
$2.87 thousand
Optionable
No Data
Beta
1.36

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:NMTR) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners